This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., University of Pennsylvania. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Althea Erica Gaffney: Innovator in HIV Treatment
Introduction
Althea Erica Gaffney is a notable inventor based in Alexandria, VA (US). She has made significant contributions to the field of medicine, particularly in the treatment of human immunodeficiency virus (HIV). Her innovative work has led to the development of compounds that offer new avenues for therapeutic intervention.
Latest Patents
Gaffney holds a patent for "Compounds for the treatment of human immunodeficiency virus." This patent includes compounds of Formula (I) or pharmaceutically acceptable salts thereof, which are designed to treat HIV-1 in subjects in need. The patent also outlines methods for stabilizing the state-1 conformation of the HIV-1 envelope glycoproteins using these compounds or pharmaceutical compositions.
Career Highlights
Throughout her career, Gaffney has worked with prestigious institutions such as the University of Pennsylvania and Dana-Farber Cancer Institute. Her research has focused on developing effective treatments for HIV, showcasing her commitment to advancing medical science.
Collaborations
Some of her notable coworkers include Amos B. Smith III and Joseph G. Sodroski. Their collaborative efforts have contributed to the success of her research and the development of her patented compounds.
Conclusion
Althea Erica Gaffney's work in the field of HIV treatment exemplifies the impact of innovative research on public health. Her contributions continue to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile